Nutcracker Therapeutics, Inc.
USPTO PatentsView assignee record - 14 granted patents across 16 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Nutcracker ranks #20,177 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 16 technology areas.
- #20,177
- of 49,997 US assignees by volume
- Top 8%
- by Innovation Score (54.6/100)
- 18.5
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R20177 · US Corporation #20,177 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 14 grants
- MID-PACK #20,177/49,997
- PHOTO-FINISH Nalpropion Pharmaceu…
- CPC-FOCUS A61K · 16 areas
- INNOV-PAR 54.6/100
- CLAIMS-RICH 18.5 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2022–2025 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Nalpropion Pharmaceuticals LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Nutcracker’s 54.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Nutcracker
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Nutcracker Therapeut… · this assignee
Nutcracker Therapeut… · this assignee
55 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Nutcracker's Innovation Score is 54.6/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Nutcracker?
Each dot is one of Nutcracker’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nutcracker’s own 18.5 claims/patent is ABOVE the 16.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Nutcracker's grants concentrate
Nutcracker Therapeutics, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 78.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (6 grants) versus a trough of 3 in 2022. By volume, Nutcracker sits between Novus Scientific AB and National Diversified Sales, Inc..
Nutcracker's three-year grant acceleration
Nutcracker Therapeutics, Inc. shows 13 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Nutcracker's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Novus Scientific…
Novus Scientific AB
14 patents
- NSI International
NSI International, Inc.
14 patents
- NTT Data Services
NTT Data Services, LLC
14 patents
- Nurix Therapeutics
Nurix Therapeutics, Inc.
14 patents
- Nalpropion Pharma…
Nalpropion Pharmaceuticals LLC
14 patents
- Nanjing Horizon R…
Nanjing Horizon Robotics Technology Co., Ltd.
14 patents
- Nanostar
Nanostar, Inc.
14 patents
- National Diversif…
National Diversified Sales, Inc.
14 patents
- Nutcracker Therap… ◀
Nutcracker Therapeutics, Inc.
14 patents
What this shows Nutcracker holds 14 patents at rank #20,152, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Nutcracker
By rank, the assignees closest to #20,152 in granted patent volume.
- Novus Scientific AB #20,148 · 14 patents
- NSI International, Inc. #20,149 · 14 patents
- NTT Data Services, LLC #20,150 · 14 patents
- Nurix Therapeutics, Inc. #20,151 · 14 patents
- Nalpropion Pharmaceuticals LLC #20,153 · 14 patents
- Nanjing Horizon Robotics Technology Co., Ltd. #20,154 · 14 patents
- Nanostar, Inc. #20,155 · 14 patents
- National Diversified Sales, Inc. #20,156 · 14 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Nutcracker's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Nutcracker's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
55 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 3 | 21.4% |
| 2023 | 4 | 28.6% |
| 2024 | 6 | 42.9% |
| 2025partial year | 1 | 7.1% |
Which technologies does Nutcracker Therapeutics, Inc. patent most?
Top 15 of 16 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Nutcracker Therapeutics, Inc.'s patent record in context - here's where to go next.
- Nutcracker Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 78.6% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #20,177 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Nutcracker Therapeutics, Inc. against Novus Scientific AB, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 54.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.